|
US20080269153A1
(en)
*
|
2002-05-28 |
2008-10-30 |
Ruxandra Draghia-Akli |
Increased stability of a dna formulation by including poly-l-glutamate
|
|
US7846720B2
(en)
*
|
2005-01-26 |
2010-12-07 |
Vgx Pharmaceuticals, Inc. |
Optimized high yield synthetic plasmids
|
|
CA2604452C
(en)
*
|
2005-04-18 |
2018-03-13 |
Francine Behar-Cohen |
Improved methods and devices for delivering a therapeutic product to the ocular sphere of a subject
|
|
FR2893256B1
(fr)
*
|
2005-11-14 |
2008-08-15 |
Yves Scherman |
Generateur d'impulsions electriques unipolaires.
|
|
CA3063263C
(en)
*
|
2006-02-11 |
2024-01-16 |
Genetronics, Inc. |
Device and method for single-needle in vivo electroporation
|
|
DE102006009157B4
(de)
*
|
2006-02-24 |
2015-08-20 |
Eisenmann Ag |
Verfahren zum Aufschließen von biologischem Material sowie Vorrichtung zu seiner Durchführung
|
|
WO2007103070A2
(en)
|
2006-03-03 |
2007-09-13 |
Genetronics, Inc. |
Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
|
|
US20090254019A1
(en)
*
|
2006-06-12 |
2009-10-08 |
Karen Julie Gehl |
Electrode introducer device
|
|
US7576549B2
(en)
*
|
2006-09-21 |
2009-08-18 |
Bio-Rad Laboratories, Inc. |
Methods for measuring sample resistance in electroporation
|
|
PT3524316T
(pt)
|
2006-10-17 |
2024-11-29 |
Inovio Pharmaceuticals Inc |
Dispositivos de eletroporação para eletroporação de células em mamíferos
|
|
ES2434169T3
(es)
|
2006-11-08 |
2013-12-13 |
Veritas Bio, Llc |
Entrega in vivo de ARN bicatenario a una célula objetivo
|
|
WO2009045813A1
(en)
*
|
2007-10-01 |
2009-04-09 |
Vgx Pharmaceuticals, Inc. |
Materials and methods for the delivery of biomolecules to cells of an organ
|
|
AU2008331673B2
(en)
|
2007-11-12 |
2014-12-11 |
The Trustees Of The University Of Pennsylvania |
Novel vaccines against multiple subtypes of influenza virus
|
|
JP2011504173A
(ja)
*
|
2007-11-14 |
2011-02-03 |
ブイジーエックス ファーマシューティカルズ，リミティド ライアビリティー カンパニー |
電気穿孔により送達されるｄｎａワクチンにより誘導される抗体の産生
|
|
WO2009099716A1
(en)
|
2008-01-11 |
2009-08-13 |
Vgx Pharmaceuticals, Inc. |
Novel vaccines against multiple subtypes of dengue virus
|
|
CN101990580A
(zh)
*
|
2008-04-04 |
2011-03-23 |
宾夕法尼亚州立大学托管会 |
屈曲病毒蛋白共有序列、编码该屈曲病毒蛋白共有序列的核酸分子和组合物及其使用方法
|
|
EP2265715B1
(en)
|
2008-04-04 |
2016-12-28 |
The Trustees Of The University Of Pennsylvania |
Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
|
|
CN102083457B
(zh)
|
2008-05-28 |
2018-05-08 |
Vgx制药有限公司 |
天花dna疫苗及其引起免疫应答的抗原
|
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
|
AU2008363596B2
(en)
|
2008-10-29 |
2015-04-30 |
Inovio Pharmaceuticals, Inc |
Improved HCV vaccines and methods for using the same
|
|
CA3001374A1
(en)
*
|
2008-11-17 |
2010-05-20 |
Vgx Pharmaceuticals, Llc |
Antigens that elicit immune response against flavivirus and methods of using same
|
|
TWI423790B
(zh)
*
|
2008-11-18 |
2014-01-21 |
Univ Nat Chiao Tung |
可調式電極植入系統及其可調式電極植入裝置
|
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
|
CA2653478A1
(en)
*
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
|
EP2498814B1
(en)
|
2009-11-02 |
2015-09-09 |
The Trustees of the University of Pennsylvania |
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
|
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
CN102781952B
(zh)
|
2010-02-08 |
2015-09-02 |
宾夕法尼亚大学托管会 |
编码rantes的核酸分子、包含其的组合物以及其使用方法
|
|
WO2012047679A2
(en)
|
2010-09-27 |
2012-04-12 |
The Trustees Of The University Of Pennsylvania |
Consensus antigen constructs and vaccines made there form, and methods of using same to treat malaria
|
|
KR101939150B1
(ko)
|
2010-11-12 |
2019-01-17 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
공통 전립선 항원, 이것을 암호화하는 핵산 분자, 그리고 이것을 포함하는 백신 및 용도
|
|
PT2667801T
(pt)
|
2011-01-28 |
2019-03-04 |
Massachusetts Gen Hospital |
Método e aparelho para dermoabrasão descontínua
|
|
KR101926752B1
(ko)
|
2011-01-28 |
2018-12-07 |
더 제너럴 하스피탈 코포레이션 |
피부 재생 방법 및 장치
|
|
WO2012103483A2
(en)
|
2011-01-28 |
2012-08-02 |
The General Hospital Corporation |
Apparatus and method for tissue biopsy
|
|
MX352974B
(es)
|
2011-01-31 |
2017-12-15 |
Univ Pennsylvania |
Moleculas de acido nucleico que codifican novedosos antigenos de herpes, vacunas que las comprenden y metodos para su uso.
|
|
EA032364B1
(ru)
|
2011-02-11 |
2019-05-31 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу
|
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
|
ITTO20110374A1
(it)
*
|
2011-04-29 |
2012-10-30 |
Igea S P A |
Metodo di controllo di un dispositivo di elettro-porazione
|
|
CA2841852C
(en)
|
2011-07-11 |
2020-06-30 |
Inovio Pharmaceuticals, Inc. |
Cross-protective arenavirus vaccines and their method of use
|
|
CN104203287B
(zh)
|
2011-07-12 |
2017-07-14 |
费城健康及教育公司，d/b/a,德雷克塞尔大学医学院 |
新型艰难梭菌dna疫苗
|
|
ES2693162T3
(es)
|
2011-07-21 |
2018-12-07 |
The General Hospital Corporation |
Instrumental para dañar y eliminar grasa
|
|
US10421960B2
(en)
|
2011-09-16 |
2019-09-24 |
The Trustees Of The University Of Pennsylvania |
RNA engineered T cells for the treatment of cancer
|
|
WO2013044225A1
(en)
|
2011-09-22 |
2013-03-28 |
The Trustees Of The University Of Pennsylvania |
A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens
|
|
WO2013055326A2
(en)
|
2011-10-12 |
2013-04-18 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
|
EP2771035B1
(en)
|
2011-10-24 |
2018-04-11 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
|
US9272002B2
(en)
|
2011-10-28 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
|
JP6407028B2
(ja)
|
2011-12-12 |
2018-10-17 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
ＭＲＳＡのＰＢＰ２ａ及びその断片を含むタンパク質、それをコードする核酸、並びにＭＲＳＡ感染を予防する及び治療するための組成物及びそれらの使用
|
|
EP3336096A1
(en)
|
2011-12-12 |
2018-06-20 |
The Trustees Of The University Of Pennsylvania |
Compositions, comprising improved il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
|
|
EP4230647A1
(en)
|
2012-02-22 |
2023-08-23 |
The Trustees of the University of Pennsylvania |
Use of icos-based cars to enhance antitumor activity and car persistence
|
|
JP2015509716A
(ja)
|
2012-02-22 |
2015-04-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
第二世代キメラ抗原受容体におけるｃｄ２シグナル伝達ドメインの使用
|
|
HK1210479A1
(en)
|
2012-04-10 |
2016-04-22 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
|
CA2870293C
(en)
|
2012-04-12 |
2023-05-09 |
The Trustees Of The University Of Pennsylvania |
Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same
|
|
JP2015524255A
(ja)
|
2012-07-13 |
2015-08-24 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
二重特異性抗体を共導入することによってｃａｒｔ細胞の活性を強化する方法
|
|
AR092745A1
(es)
|
2012-10-01 |
2015-04-29 |
Univ Pennsylvania |
Composiciones que comprenden un dominio de union anti-fap y metodos para hacer blanco en celulas estromales para el tratamiento del cancer
|
|
WO2014055771A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Human alpha-folate receptor chimeric antigen receptor
|
|
WO2014055657A1
(en)
|
2012-10-05 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Use of a trans-signaling approach in chimeric antigen receptors
|
|
EP2911736A4
(en)
*
|
2012-10-25 |
2016-06-15 |
Oncosec Medical Inc |
electroporation
|
|
CN104812401B
(zh)
|
2012-12-13 |
2017-10-13 |
宾夕法尼亚大学理事会 |
Wt1疫苗
|
|
BR112015019440A8
(pt)
|
2013-02-20 |
2019-11-12 |
Cytrellis Biosystems Inc |
curativo regulável, kit, uso e método para fortalecimento da pele
|
|
AU2014248535B2
(en)
|
2013-03-12 |
2017-03-30 |
Inovio Pharmaceuticals, Inc. |
Improved vaccines for human papilloma virus and methods for using the same
|
|
EP2968607B1
(en)
|
2013-03-15 |
2019-07-24 |
The Trustees Of The University Of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
|
CA2895806C
(en)
|
2013-03-15 |
2023-02-21 |
The Trustees Of The University Of Pennsylvania |
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
|
|
US11013917B2
(en)
|
2013-06-21 |
2021-05-25 |
Newsouth Innovations Pty Limited |
Method and apparatus for close-field electroporation
|
|
BR112016002695B1
(pt)
|
2013-08-09 |
2022-09-20 |
Cytrellis Biosystems, Inc |
Dispositivo com um aparelho ablativo, um aparelho de remoção e um aparelho de posicionamento
|
|
CN203451533U
(zh)
*
|
2013-08-27 |
2014-02-26 |
苏州文曲生物微系统有限公司 |
一种基于新型微电极芯片的电穿孔系统
|
|
CN105829341A
(zh)
|
2013-12-13 |
2016-08-03 |
宾夕法尼亚大学理事会 |
Dna抗体构建体及其使用方法
|
|
US10953143B2
(en)
|
2013-12-19 |
2021-03-23 |
Cytrellis Biosystems, Inc. |
Methods and devices for manipulating subdermal fat
|
|
EP4303229A3
(en)
|
2014-01-21 |
2024-04-17 |
Novartis AG |
Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules
|
|
EP4653013A2
(en)
|
2014-10-31 |
2025-11-26 |
The Trustees of the University of Pennsylvania |
Methods and compositions for modified t cells
|
|
CN107206024B
(zh)
|
2014-10-31 |
2021-12-03 |
宾夕法尼亚大学董事会 |
改变cart细胞中的基因表达及其用途
|
|
CN107106609A
(zh)
|
2014-10-31 |
2017-08-29 |
宾夕法尼亚大学董事会 |
刺激和扩展t细胞的组合物和方法
|
|
JP2017533774A
(ja)
|
2014-11-14 |
2017-11-16 |
サイトレリス バイオシステムズ，インコーポレーテッド |
皮膚のアブレーションのためのデバイス及び方法
|
|
CA2969214A1
(en)
|
2014-12-01 |
2016-06-09 |
The Trustees Of The University Of Pennsylvania |
Dna antibody constructs and method of using same
|
|
EP3799879B1
(en)
|
2015-01-09 |
2025-06-04 |
Grand Decade Developments Limited |
Gene therapy using co-stimulatory molecule and cytokine for the treatment of malignancies
|
|
ES2947589T3
(es)
|
2015-01-31 |
2023-08-11 |
Univ Pennsylvania |
Composiciones y métodos para el suministro de moléculas terapéuticas a linfocitos T
|
|
EP3286311B1
(en)
|
2015-03-26 |
2021-05-05 |
OncoSec Medical Incorporated |
Method for the treatment of malignancies
|
|
ES2807439T3
(es)
*
|
2015-03-31 |
2021-02-23 |
Oncosec Medical Inc |
Sistemas para electroporación mejorada basada en la detección de tejidos
|
|
RU2754661C2
(ru)
|
2015-05-01 |
2021-09-06 |
Дзе Реджентс Оф Дзе Юниверсити Оф Калифорния |
Гликанзависимые иммунотерапевтические молекулы
|
|
NZ737871A
(en)
|
2015-06-25 |
2023-02-24 |
Newsouth Innovations Pty Ltd |
Electroporation system for controlled localized therapeutics delivery
|
|
EP4218777A3
(en)
|
2015-08-28 |
2023-08-23 |
The Trustees of the University of Pennsylvania |
Methods and compositions for cells expressing a chimeric intracellular signaling molecule
|
|
KR101788301B1
(ko)
*
|
2015-09-17 |
2017-10-20 |
주식회사 엘림텍 |
전기천공장치 및 그 제어방법
|
|
JP7079729B2
(ja)
|
2015-12-18 |
2022-06-02 |
オンコセック メディカル インコーポレイテッド |
異種タンパク質発現のためのプラスミド構築物及びその使用方法
|
|
IL260071B2
(en)
*
|
2015-12-22 |
2023-03-01 |
Inovio Pharmaceuticals Inc |
An electroporation device that includes a battery pack with a power switch
|
|
CN118184761A
(zh)
|
2016-02-05 |
2024-06-14 |
因诺维奥制药公司 |
癌症疫苗和使用其的治疗方法
|
|
WO2017165683A1
(en)
|
2016-03-23 |
2017-09-28 |
Novartis Ag |
Cell secreted minibodies and uses thereof
|
|
KR20250162900A
(ko)
|
2016-03-29 |
2025-11-19 |
사이트렐리스 바이오시스템즈, 인크. |
미용 피부 리설페이싱용 디바이스 및 방법
|
|
AU2017249424B2
(en)
|
2016-04-13 |
2023-08-24 |
Janssen Pharmaceuticals, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
|
JP2018035137A
(ja)
|
2016-07-13 |
2018-03-08 |
マブイミューン ダイアグノスティックス エイジーＭａｂｉｍｍｕｎｅ Ｄｉａｇｎｏｓｔｉｃｓ Ａｇ |
新規な抗線維芽細胞活性化タンパク質（ｆａｐ）結合薬剤およびその使用
|
|
BR112019005312A2
(pt)
|
2016-09-21 |
2019-07-16 |
Cytrellis Biosystems Inc |
dispositivos e métodos para a recomposição cosmética da pele
|
|
CN110073002B
(zh)
|
2016-10-17 |
2024-06-11 |
杨森制药公司 |
重组病毒复制子体系及其用途
|
|
MX2019006467A
(es)
|
2016-12-05 |
2019-12-09 |
Janssen Pharmaceuticals Inc Star |
Composiciones y métodos para mejorar la expresión génica.
|
|
AU2018246143B2
(en)
|
2017-03-28 |
2025-06-05 |
The Trustees Of The University Of Pennsylvania |
Methods to protect transplanted tissue from rejection
|
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
|
SE541651C2
(en)
|
2017-07-28 |
2019-11-19 |
Scandinavian Chemotech Ab |
An electrode device and a needle electrode for use in delivery of electrical pulses to a desired tissue of a mammal
|
|
AU2018383663B2
(en)
|
2017-12-13 |
2023-12-21 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting BORIS and uses thereof
|
|
KR102637862B1
(ko)
|
2017-12-13 |
2024-02-19 |
이노비오 파마수티컬즈, 인크. |
메소텔린을 표적으로 하는 암 백신 및 이의 용도
|
|
AU2018383662C1
(en)
|
2017-12-13 |
2023-02-09 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting MUC16 and uses thereof
|
|
FI3737397T3
(fi)
|
2017-12-13 |
2023-03-18 |
Inovio Pharmaceuticals Inc |
Prameen kohdistetut syöpärokotteet ja niiden käytöt
|
|
EA202091517A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и устройство для доставки вакцин против вируса гепатита b (hbv)
|
|
US11020476B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV)
|
|
MX2020006480A
(es)
|
2017-12-19 |
2020-09-22 |
Janssen Sciences Ireland Unlimited Co |
Vacunas contra el virus de la hepatitis b (hbv) y usos de las mismas.
|
|
US11021692B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B virus (HBV) vaccines and uses thereof
|
|
KR20200100745A
(ko)
|
2017-12-19 |
2020-08-26 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
B형 간염 바이러스(hbv)에 대한 면역 반응 유도를 위한 방법 및 조성물
|
|
WO2019129851A1
(en)
|
2017-12-29 |
2019-07-04 |
Cellectis |
Method for improving production of car t cells
|
|
EP3740245A4
(en)
|
2018-01-19 |
2022-01-05 |
Janssen Pharmaceuticals, Inc. |
INDUCTION AND ENHANCEMENT OF IMMUNE RESPONSES USING RECOMBINATION REPLICON SYSTEMS
|
|
WO2019191114A1
(en)
|
2018-03-27 |
2019-10-03 |
The Trustees Of The University Of Pennsylvania |
Modified immune cells having enhanced function and methods for screening for same
|
|
US12343397B2
(en)
|
2018-05-17 |
2025-07-01 |
Regents Of The University Of Minnesota |
Drug-resistant immune cells and methods of use thereof
|
|
WO2020037142A1
(en)
|
2018-08-17 |
2020-02-20 |
Yale University |
Compositions and methods for high-throughput activation screening to boost t cell effector function
|
|
MX2021004032A
(es)
|
2018-10-08 |
2021-07-06 |
Janssen Pharmaceuticals Inc |
Replicones basados en alfavirus para la administracion de bioterapeuticos.
|
|
US20220170097A1
(en)
|
2018-10-29 |
2022-06-02 |
The Broad Institute, Inc. |
Car t cell transcriptional atlas
|
|
US11185692B2
(en)
*
|
2018-10-31 |
2021-11-30 |
Emily Ireland |
Light touch therapeutic headset
|
|
TWI850282B
(zh)
|
2018-11-27 |
2024-08-01 |
香港商弘年發展有限公司 |
用於治療癌症之質體建構體和使用方法
|
|
US11071860B2
(en)
|
2019-02-06 |
2021-07-27 |
Oncosec Medical Incorporated |
Systems and methods for detecting fault conditions in electroporation therapy
|
|
US20220177863A1
(en)
|
2019-03-18 |
2022-06-09 |
The Broad Institute, Inc. |
Type vii crispr proteins and systems
|
|
CN113661180B
(zh)
|
2019-03-27 |
2025-08-26 |
宾夕法尼亚大学董事会 |
Tn-MUC1嵌合抗原受体(CAR)T细胞疗法
|
|
US11660139B2
(en)
|
2019-04-10 |
2023-05-30 |
Radioclash Inc. |
Electroporation probe
|
|
CN109999340B
(zh)
*
|
2019-04-29 |
2024-07-16 |
杭州睿笛生物科技有限公司 |
一种负载自适应纳秒脉冲产生装置
|
|
US20220305107A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi
|
|
WO2020255035A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyrimidine derivatives
|
|
US20220233684A1
(en)
|
2019-06-18 |
2022-07-28 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pd-l1 inhibitors
|
|
WO2020255017A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
|
TWI772823B
(zh)
|
2019-06-18 |
2022-08-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
B型肝炎病毒(hbv)疫苗與蛋白殼組裝調節劑之組合
|
|
US20220324916A1
(en)
|
2019-06-18 |
2022-10-13 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B Virus (HBV) Vaccines and Uses Thereof
|
|
WO2020255013A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and capsid assembly modulators being amide derivatives
|
|
WO2020255016A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
|
WO2020255015A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and dihydropyrimidine derivatives as capsid assembly modulators
|
|
WO2020255010A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of recombinant interleukin 12 construct and hepatitis b virus (hbv) vaccines
|
|
US20220305115A1
(en)
|
2019-06-18 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
WO2020255022A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and aminopyridine derivatives as hpk1 inhibitors
|
|
JP2022536850A
(ja)
|
2019-06-18 |
2022-08-19 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
Ｂ型肝炎ウイルス（ｈｂｖ）ワクチンおよび抗ｐｄ－１または抗ｐｄ－ｌ１抗体の組合せ
|
|
CA3140588A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and small molecule pdl1 or pd1 inhibitor
|
|
KR20220042116A
(ko)
|
2019-06-18 |
2022-04-04 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
B형 간염 바이러스(HBV) 백신 및 HBV-타케팅 RNAi의 조합
|
|
WO2020255042A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a pyrimidine derivative
|
|
WO2020254876A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Virus-like particle delivery of hepatitis b virus (hbv) vaccines
|
|
CA3140707A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and quinazoline derivatives
|
|
CA3143634A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and anti-pd-1 antibody
|
|
EP3986915A1
(en)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Recombinant interleukin 12 construct and uses thereof
|
|
WO2020255019A1
(en)
|
2019-06-18 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Combination of hepatitis b virus (hbv) vaccines and a quinazoline derivative
|
|
AU2020297019A1
(en)
|
2019-06-20 |
2022-02-17 |
Janssen Sciences Ireland Unlimited Company |
Carbohydrate nanocarrier delivery of hepatitis B virus (HBV) vaccines
|
|
US20220305108A1
(en)
|
2019-06-20 |
2022-09-29 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
|
TWI883032B
(zh)
|
2019-08-12 |
2025-05-11 |
中國大陸商北京恩瑞尼生物科技股份有限公司 |
藉由adcc靶向cd39表現細胞促進及增強t細胞介導免疫反應之方法及組合物
|
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
|
WO2021108050A2
(en)
|
2019-10-23 |
2021-06-03 |
Yale University |
Compositions and methods comprising viral vector systems for multiplexed activation of endogenous genes as immunotherapy and viral-based immune-gene therapy
|
|
WO2021178896A1
(en)
|
2020-03-06 |
2021-09-10 |
Go Therapeutics, Inc. |
Anti-glyco-cd44 antibodies and their uses
|
|
US20210322471A1
(en)
|
2020-03-27 |
2021-10-21 |
Dcprime B.V. |
In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
|
|
JP2023519346A
(ja)
|
2020-03-27 |
2023-05-10 |
メンドゥス・ベスローテン・フェンノートシャップ |
養子細胞療法の有効性を増強するための白血病由来の改変細胞のエクスビボ（ｅｘ ｖｉｖｏ）使用
|
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
|
AU2021289600A1
(en)
|
2020-06-12 |
2023-01-19 |
University Of Rochester |
Encoding and expression of ACE-tRNAs
|
|
CA3182607A1
(en)
|
2020-06-30 |
2022-01-06 |
Erik Hans MANTING |
Use of leukemia-derived cells in ovarian cancer vaccines
|
|
CA3188801A1
(en)
|
2020-07-08 |
2022-01-13 |
Janssen Sciences Ireland Unlimited Company |
Rna replicon vaccines against hbv
|
|
EP4210832A1
(en)
|
2020-09-14 |
2023-07-19 |
Vor Biopharma, Inc. |
Chimeric antigen receptors for treatment of cancer
|
|
WO2022097068A1
(en)
|
2020-11-05 |
2022-05-12 |
Dcprime B.V. |
Use of tumor-independent antigens in immunotherapies
|
|
WO2022133230A1
(en)
|
2020-12-18 |
2022-06-23 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
|
JP2024501022A
(ja)
|
2020-12-28 |
2024-01-10 |
アークトゥルス セラピューティクス， インコーポレイテッド |
Ｈｂｖを標的とする転写活性化因子様エフェクターヌクレアーゼ（ｔａｌｅｎ）
|
|
EP4281102A1
(en)
|
2021-01-22 |
2023-11-29 |
Mendus B.V. |
Methods of tumor vaccination
|
|
WO2022187591A1
(en)
|
2021-03-05 |
2022-09-09 |
Go Therapeutics, Inc. |
Anti-glyco-cd44 antibodies and their uses
|
|
US20220305100A1
(en)
|
2021-03-12 |
2022-09-29 |
Dcprime B.V. |
Methods of vaccination and use of cd47 blockade
|
|
JP2024522909A
(ja)
*
|
2021-06-30 |
2024-06-21 |
イノビオ ファーマシューティカルズ，インコーポレイティド |
電気穿孔のための電極アレイ、並びに関連するシステム及び方法
|
|
US20240352481A1
(en)
|
2021-07-29 |
2024-10-24 |
Vor Biopharma Inc. |
Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same
|
|
WO2023010126A2
(en)
|
2021-07-29 |
2023-02-02 |
Vor Biopharma Inc. |
Chimeric antigen receptors for treatment of cancer
|
|
US20250101126A1
(en)
|
2021-08-05 |
2025-03-27 |
Go Therapeutics, Inc. |
Anti-glyco-muc4 antibodies and their uses
|
|
AU2022339667A1
(en)
|
2021-09-03 |
2024-04-11 |
Go Therapeutics, Inc. |
Anti-glyco-cmet antibodies and their uses
|
|
WO2023034571A1
(en)
|
2021-09-03 |
2023-03-09 |
Go Therapeutics, Inc. |
Anti-glyco-lamp1 antibodies and their uses
|
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
|
AU2023262112A1
(en)
|
2022-04-29 |
2024-10-31 |
Purinomia Biotech, Inc. |
Methods and compositions for treating eosinophil driven diseases and disorders
|
|
EP4518957A1
(en)
*
|
2022-05-05 |
2025-03-12 |
Renbio, Inc. |
Device related to therapeutic dna delivery
|
|
US20240002800A1
(en)
|
2022-05-16 |
2024-01-04 |
Mendus B.V. |
Use of leukemia-derived cells for enhancing natural killer (nk) cell therapy
|
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
|
EP4634373A1
(en)
|
2022-12-16 |
2025-10-22 |
University of Rochester |
Repairment of barrier dysfunction in esophagus
|
|
WO2024236547A1
(en)
|
2023-05-18 |
2024-11-21 |
Inceptor Bio, Llc |
Modified phagocytic cells expressing chimeric antigen receptors comprising a herpes virus entry mediator (hvem) co-stimulatory domain and uses thereof
|
|
WO2025046513A1
(en)
|
2023-08-29 |
2025-03-06 |
Inceptor Bio, Llc |
Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof
|
|
WO2025101685A1
(en)
|
2023-11-09 |
2025-05-15 |
University Of Rochester |
Suppression of nonsense mutations using anticodon engineered (ace)-trnas
|
|
US12484963B2
(en)
*
|
2024-04-03 |
2025-12-02 |
Field Medical, Inc. |
Systems and methods for affecting a target tissue via a pulsed field
|